BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 38765262)

  • 1. Circulating Sphingolipids and All-Cause Mortality: The Strong Heart Family Study.
    Fretts AM; Jensen PN; Sitlani CM; Hoofnagle A; Lidgard B; Umans JG; Siscovick DS; King IB; Howard BV; Cole SA; Lemaitre RN
    J Am Heart Assoc; 2024 Jun; ():e032536. PubMed ID: 38904223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma Biomarkers of Brain Injury and Their Association With Brain MRI and Cognition in Type 1 Diabetes.
    Karger AB; Nasrallah IM; Braffett BH; Luchsinger JA; Ryan CM; Bebu I; Arends V; Habes M; Gubitosi-Klug RA; Chaytor N; Biessels GJ; Jacobson AM;
    Diabetes Care; 2024 Jun; ():. PubMed ID: 38861647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between neighborhood greenspace and brain imaging measures in non-demented older adults: the Cardiovascular Health Study.
    Besser LM; Lovasi GS; Michael YL; Garg P; Hirsch JA; Siscovick D; Hurvitz P; Biggs ML; Galvin JE; Bartz TM; Longstreth WT
    Soc Psychiatry Psychiatr Epidemiol; 2021 Sep; 56(9):1575-1585. PubMed ID: 33388800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interactive effect of intra-beat and inter-beat blood pressure variability on neurodegeneration in older adults.
    Lohman T; Shenasa F; Sible I; Kapoor A; Engstrom AC; Dutt S; Head E; Sordo L; M Alitin JP; Gaubert A; Nguyen A; Nation DA
    medRxiv; 2024 May; ():. PubMed ID: 38746307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating sphingolipids and subclinical brain pathology: the cardiovascular health study.
    Moseholm KF; Horn JW; Fitzpatrick AL; Djoussé L; Longstreth WT; Lopez OL; Hoofnagle AN; Jensen MK; Lemaitre RN; Mukamal KJ
    Front Neurol; 2024; 15():1385623. PubMed ID: 38765262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Serum Neurofilament Light Chain Concentration and MRI Findings in Older Adults: The Cardiovascular Health Study.
    Fohner AE; Bartz TM; Tracy RP; Adams HHH; Bis JC; Djousse L; Satizabal CL; Lopez OL; Seshadri S; Mukamal KJ; Kuller LH; Psaty BM; Longstreth WT
    Neurology; 2022 Mar; 98(9):e903-e911. PubMed ID: 34921102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma Ceramides and Sphingomyelins and Sudden Cardiac Death in the Cardiovascular Health Study.
    Bockus LB; Jensen PN; Fretts AM; Hoofnagle AN; McKnight B; Sitlani CM; Siscovick DS; King IB; Psaty BM; Sotoodehnia N; Lemaitre RN
    JAMA Netw Open; 2023 Nov; 6(11):e2343854. PubMed ID: 37976059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal associations of serum biomarkers with early cognitive, amyloid and grey matter changes.
    De Meyer S; Blujdea ER; Schaeverbeke J; Reinartz M; Luckett ES; Adamczuk K; Van Laere K; Dupont P; Teunissen CE; Vandenberghe R; Poesen K
    Brain; 2024 Mar; 147(3):936-948. PubMed ID: 37787146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Ceramides and Sphingomyelins in Relation to Atrial Fibrillation Risk: The Cardiovascular Health Study.
    Jensen PN; Fretts AM; Hoofnagle AN; Sitlani CM; McKnight B; King IB; Siscovick DS; Psaty BM; Heckbert SR; Mozaffarian D; Sotoodehnia N; Lemaitre RN
    J Am Heart Assoc; 2020 Feb; 9(4):e012853. PubMed ID: 32019406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's and neurodegenerative disease biomarkers in blood predict brain atrophy and cognitive decline.
    Dark HE; An Y; Duggan MR; Joynes C; Davatzikos C; Erus G; Lewis A; Moghekar AR; Resnick SM; Walker KA
    Alzheimers Res Ther; 2024 Apr; 16(1):94. PubMed ID: 38689358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum NfL and GFAP are associated with incident dementia and dementia mortality in older adults: The cardiovascular health study.
    Cronjé HT; Liu X; Odden MC; Moseholm KF; Seshadri S; Satizabal CL; Lopez OL; Bis JC; Djoussé L; Fohner AE; Psaty BM; Tracy RP; Longstreth WT; Jensen MK; Mukamal KJ
    Alzheimers Dement; 2023 Dec; 19(12):5672-5680. PubMed ID: 37392405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging roles and therapeutic potentials of sphingolipids in pathophysiology: emphasis on fatty acyl heterogeneity.
    Mu J; Lam SM; Shui G
    J Genet Genomics; 2024 Mar; 51(3):268-278. PubMed ID: 37364711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceramide in cerebrovascular diseases.
    Yuan H; Zhu B; Li C; Zhao Z
    Front Cell Neurosci; 2023; 17():1191609. PubMed ID: 37333888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The global burden of cerebral small vessel disease in low- and middle-income countries: A systematic review and meta-analysis.
    Lam BYK; Cai Y; Akinyemi R; Biessels GJ; van den Brink H; Chen C; Cheung CW; Chow KN; Chung HKH; Duering M; Fu ST; Gustafson D; Hilal S; Hui VMH; Kalaria R; Kim S; Lam MLM; de Leeuw FE; Li ASM; Markus HS; Marseglia A; Zheng H; O'Brien J; Pantoni L; Sachdev PS; Smith EE; Wardlaw J; Mok VCT
    Int J Stroke; 2023 Jan; 18(1):15-27. PubMed ID: 36282189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-Omic analyses characterize the ceramide/sphingomyelin pathway as a therapeutic target in Alzheimer's disease.
    Baloni P; Arnold M; Buitrago L; Nho K; Moreno H; Huynh K; Brauner B; Louie G; Kueider-Paisley A; Suhre K; Saykin AJ; Ekroos K; Meikle PJ; Hood L; Price ND; ; Doraiswamy PM; Funk CC; Hernández AI; Kastenmüller G; Baillie R; Han X; Kaddurah-Daouk R
    Commun Biol; 2022 Oct; 5(1):1074. PubMed ID: 36209301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal Fluid Sphingomyelins in Alzheimer's Disease, Neurodegeneration, and Neuroinflammation.
    Morrow A; Panyard DJ; Deming YK; Jonaitis E; Dong R; Vasiljevic E; Betthauser TJ; Kollmorgen G; Suridjan I; Bayfield A; Van Hulle CA; Zetterberg H; Blennow K; Carlsson CM; Asthana S; Johnson SC; Engelman CD
    J Alzheimers Dis; 2022; 90(2):667-680. PubMed ID: 36155504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating ceramides and sphingomyelins and the risk of incident cardiovascular disease among people with diabetes: the strong heart study.
    Jensen PN; Fretts AM; Hoofnagle AN; McKnight B; Howard BV; Umans JG; Sitlani CM; Siscovick DS; King IB; Sotoodehnia N; Lemaitre RN
    Cardiovasc Diabetol; 2022 Aug; 21(1):167. PubMed ID: 36042511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Sphingolipids Pathway in Parkinson's Disease: From GCase to Integrated-Biomarker Discovery.
    Esfandiary A; Finkelstein DI; Voelcker NH; Rudd D
    Cells; 2022 Apr; 11(8):. PubMed ID: 35456032
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.